Search

everythinglearnresearchcommunity

for

Search:↓

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

The woman was diagnosed with Vogt–Koyanagi–Harada disease and successfully treated with medication, restoring her vision and stopping headaches.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

New treatments for male hypogonadism are effective and should be personalized.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

The R343H mutation in the VDR gene causes vitamin D-resistant rickets with alopecia by impairing specific gene activity.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

Some people have genetic mutations that make them resistant to vitamin D, leading to rickets even with enough vitamin D intake.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

A child with rickets and hair loss might have a rare type of rickets that doesn't improve much with usual vitamin D and calcium treatment.